Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ashley I. Michnick, Ph.D., Pharm.D.

Concepts (13)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Ashley Michnick's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Ashley Michnick has written about over time.
Aged, 1 publications between 2024 and 2024, average publication date November 2024. Aged, 80 and over, 1 publications between 2024 and 2024, average publication date November 2024. Alzheimer Disease, 1 publications between 2024 and 2024, average publication date November 2024. Antipsychotic Agents, 1 publications between 2024 and 2024, average publication date November 2024. Cholinergic Antagonists, 1 publications between 2024 and 2024, average publication date November 2024. Dementia, 1 publications between 2024 and 2024, average publication date November 2024. Female, 1 publications between 2024 and 2024, average publication date November 2024. Humans, 1 publications between 2024 and 2024, average publication date November 2024. Hypnotics and Sedatives, 1 publications between 2024 and 2024, average publication date November 2024. Inappropriate Prescribing, 1 publications between 2024 and 2024, average publication date November 2024. Male, 1 publications between 2024 and 2024, average publication date November 2024. Patient Education as Topic, 1 publications between 2024 and 2024, average publication date November 2024. Prospective Studies, 1 publications between 2024 and 2024, average publication date November 2024.

To see the data from this visualization as text, click here.
Michnick's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (13)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.